Terbinafine Tablet
Product Images NDC 76282-209

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 76282-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

Terbinafine Tablets, USP 250 mg oral tablets packaging label by Exelan Pharmaceuticals Inc. The label indicates 30 tablets in the container, with NDC 76282-209-30. Instructions advise pharmacists to dispense with the patient information leaflet. Storage instructions and manufacturer details are also present, including Ivagen Pharmaceuticals, Inc. as manufacturer and Exelan Pharmaceuticals, Inc. as labeler.*

FDA Label Image

Structure (Structure)

Chemical structure of terbinafine hydrochloride, showing its molecular framework including naphthalene and allylamine groups, associated with HCl.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.